We observe that exosomes from pancreatic cancer cell lines, independently from the KRAS mutation status, can initiate the transformation of NIH/3T3 cells, while exosomes from normal pancreatic cells do not possess this ability. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.